Duncker Streett & Co. Inc. trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 39.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,073 shares of the company’s stock after selling 2,695 shares during the quarter. Duncker Streett & Co. Inc.’s holdings in Cardinal Health were worth $273,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also bought and sold shares of CAH. BlackRock Inc. boosted its holdings in shares of Cardinal Health by 1,041.8% in the 1st quarter. BlackRock Inc. now owns 21,444,922 shares of the company’s stock worth $1,748,835,000 after purchasing an additional 19,566,764 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Cardinal Health by 72.1% in the 2nd quarter. Franklin Resources Inc. now owns 6,283,529 shares of the company’s stock worth $489,613,000 after purchasing an additional 2,632,836 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in shares of Cardinal Health by 71.4% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,557,123 shares of the company’s stock worth $277,191,000 after purchasing an additional 1,482,285 shares in the last quarter. HealthCor Management L.P. purchased a new position in shares of Cardinal Health in the 2nd quarter worth about $84,496,000. Finally, Teachers Advisors LLC boosted its holdings in shares of Cardinal Health by 141.3% in the 2nd quarter. Teachers Advisors LLC now owns 1,637,285 shares of the company’s stock worth $127,577,000 after purchasing an additional 958,792 shares in the last quarter. Institutional investors and hedge funds own 87.26% of the company’s stock.
A number of equities analysts have recently issued reports on the company. BidaskClub cut Cardinal Health from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Jefferies Group LLC reiterated a “hold” rating and issued a $77.00 price objective on shares of Cardinal Health in a report on Thursday, July 27th. Credit Suisse Group cut their price objective on Cardinal Health from $87.00 to $81.00 and set an “outperform” rating for the company in a report on Thursday, August 3rd. UBS AG reissued a “neutral” rating and issued a $76.00 target price (down previously from $79.00) on shares of Cardinal Health in a research note on Thursday, August 3rd. Finally, Cowen and Company reissued a “market perform” rating and issued a $77.00 target price (down previously from $82.00) on shares of Cardinal Health in a research note on Thursday, August 3rd. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and five have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $74.81.
ILLEGAL ACTIVITY WARNING: “Duncker Streett & Co. Inc. Sells 2,695 Shares of Cardinal Health, Inc. (NYSE:CAH)” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/11/12/cardinal-health-inc-cah-holdings-reduced-by-duncker-streett-co-inc.html.
Cardinal Health, Inc. (CAH) opened at $58.55 on Friday. The company has a market capitalization of $19,052.39, a P/E ratio of 11.49, a price-to-earnings-growth ratio of 1.75 and a beta of 0.88. The company has a current ratio of 1.06, a quick ratio of 0.80 and a debt-to-equity ratio of 1.35. Cardinal Health, Inc. has a 52-week low of $57.54 and a 52-week high of $84.88.
Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Monday, November 6th. The company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. Cardinal Health’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.24 EPS. equities research analysts forecast that Cardinal Health, Inc. will post 4.97 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.4624 per share. This represents a $1.85 dividend on an annualized basis and a yield of 3.16%. The ex-dividend date of this dividend is Friday, December 29th. Cardinal Health’s payout ratio is 53.78%.
Cardinal Health Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.